Acupuncture for Cancer-Related Cognitive Impairment
Recruiting at 7 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 4 JurisdictionsThis treatment is already approved in other countries
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is exploring whether acupuncture can help improve cognitive difficulties in cancer patients by stimulating the body to heal itself.
Who Is on the Research Team?
Jun Mao, MD, MSCE
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 who've finished initial cancer treatment at least a month ago and feel their memory or concentration has worsened since their diagnosis. They must not have active disease, recent acupuncture for cognition, certain psychiatric disorders, dementia, Parkinson's, or recent medication changes.Inclusion Criteria
Must be English-speaking
I finished my initial cancer treatment over a month ago but may be on maintenance therapy.
I am willing to follow the study's procedures and accept being randomly assigned to real or sham acupuncture.
See 3 more
Exclusion Criteria
My disease is currently active.
I haven't started or changed any sleep, calm, or mood medications in the last 8 weeks.
I have been diagnosed with a brain disorder such as Alzheimer's or Parkinson's.
See 3 more
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Treatment
Participants receive acupuncture or sham acupuncture to assess its impact on cognitive difficulties
16 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
4 weeks
What Are the Treatments Tested in This Trial?
Interventions
- 16 week waiting period + optional Acupuncture
- Acupuncture
- Sham Acupuncture
Trial Overview The study tests if acupuncture can help with cognitive issues in cancer patients. Participants will be randomly assigned to receive either real acupuncture or sham (placebo) acupuncture. There's also an option of a waiting period followed by optional acupuncture.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Wait-List ControlExperimental Treatment1 Intervention
This arm is Closed to accrual.
Group II: AcupunctureExperimental Treatment1 Intervention
Group III: Sham Acupuncture (SA)Placebo Group1 Intervention
Acupuncture is already approved in United States, European Union, China for the following indications:
Approved in United States as Acupuncture for:
- Pain management
- Hot flashes
- Fatigue
- Sleep disturbances
- Anxiety
- Depression
- Neuropathy
Approved in European Union as Acupuncture for:
- Pain management
- Hot flashes
- Fatigue
- Sleep disturbances
- Anxiety
- Depression
Approved in China as Acupuncture for:
- Pain management
- Hot flashes
- Fatigue
- Sleep disturbances
- Anxiety
- Depression
- Neuropathy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
Trials
1,998
Recruited
602,000+
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.